Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Kalman Daniel — Inhibikase Therapeutics, Inc. insider · InsiderLens

Home / Insiders / Kalman Daniel

Kalman Daniel

10% owner at Inhibikase Therapeutics, Inc. · on record since Dec 22, 2020

Insider trading activity of Kalman Daniel

No transactions on record for Kalman Daniel.

Track record of Kalman Daniel

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kalman Daniel

Co-insiders of Kalman Daniel

Bellini RobertoInhibikase Therapeutics, Inc.
BERMAN DENNIS NInhibikase Therapeutics, Inc.
Cabell ChristopherInhibikase Therapeutics, Inc.
Canner DavidInhibikase Therapeutics, Inc.
Dion GiseleInhibikase Therapeutics, Inc.
FRATTAROLI JOSEPHInhibikase Therapeutics, Inc.
Freeman Roy LesterInhibikase Therapeutics, Inc.
GRINT PAUL CInhibikase Therapeutics, Inc.
Iwicki Mark TInhibikase Therapeutics, Inc.
Kush ArvindInhibikase Therapeutics, Inc.
Lees-Rolfe GarthInhibikase Therapeutics, Inc.
McIntyre DavidInhibikase Therapeutics, Inc.
Munshi AmitInhibikase Therapeutics, Inc.
O'Farrell Elizabeth G.Inhibikase Therapeutics, Inc.
Sands Capital Life Sciences Pulse Fund II, L.P.Inhibikase Therapeutics, Inc.
Sands Capital Ventures, LLCInhibikase Therapeutics, Inc.
SANDS FRANK M.Inhibikase Therapeutics, Inc.
Vincent AurentzInhibikase Therapeutics, Inc.
Werner Milton H.Inhibikase Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters